Manufacturer
538 recalls in our database name Aidapak Services, LLC as the manufacturing or recalling firm.
Of the 538 recalls from Aidapak Services, LLC we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 127 (24%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Aidapak Services is recalling 1 mg tacrolimus capsules that may have been mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.
Aidapak Services is recalling Entecavir tablets because they may be mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Venlafaxine HCL 25 mg tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling 493 Acyclovir 200 mg capsules because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling 81 mg Aspirin DR EC tablets because they may have been mislabeled as Sotalol HCl or Folic Acid.
Aidapak Services is recalling Methazolamide tablets that may have been mislabeled as Buprenorphine HCL due to a label mixup.
Aidapak Services is recalling Levothyroxine Sodium 112 mcg tablets because they may have been mislabeled as Raltegravir 400 mg.
Aidapak Services, LLC is recalling Docusate Sodium capsules because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.
Aidapak Services is recalling Valsartan 40 mg tablets because they may have been mislabeled as Valsartan 80 mg or Zinc Sulfate 50 mg.
Aidapak Services, LLC is recalling Modafinil 200 mg tablets because they may have been mislabeled as Omega-3-Acid Ethyl Esters capsules.
Aidapak Services is recalling Efavirenz 600 mg tablets because they may have been mislabeled as Niacin ER 500 mg.
Aidapak Services is recalling Famciclovir 500 mg tablets because they may have been mislabeled as Tolterodine or Thiamine.
Aidapak Services, LLC is recalling prednisone 20 mg tablets that may have been mislabeled as methylprednisolone 4 mg.
Aidapak Services, LLC is recalling glyBURIDE tablets because they may have been mislabeled as CYPROHEPTADINE HCL or AMANTADINE HCL.
Aidapak Services is recalling 811 tablets of 20 mg Atorvastatin Calcium because they may be mislabeled as other drugs.
Aidapak Services, LLC is recalling Mesalamine DR capsules that may have been mislabeled as Chlorophyllin Copper Complex tablets.
Aidapak Services is recalling Oxybutynin Chloride tablets that may be mislabeled as Pimozide. The error could lead to patients receiving the wrong medication.
Aidapak Services, LLC is recalling Pyridoxine HCL 100 mg tablets because they may have been mislabeled as other drugs. The repacked drugs were distributed in four western states.
Aidapak Services is recalling 1,101 chlordiazepoxide capsules because they may have been mislabeled as other medications. The affected drugs were distributed in four western states.
Aidapak Services, LLC is recalling 40 mg atorvastatin calcium tablets that may have been mislabeled as 10 mg atorvastatin or 5 mg finasteride.
Aidapak Services is recalling Hyoscyamine Sulfate ODT tablets that may have been mislabeled as Fluoxetine HCl capsules.
Aidapak Services, LLC is recalling Calcium Carbonate/Cholecalciferol tablets because they may be mislabeled as Repaglinide. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Aidapak Services, LLC is recalling Nabumetone 500 mg tablets that may have been mislabeled as guaiFENesin ER 600 mg. The FDA classifies this as a Class II recall.
Aidapak Services is recalling Levothyroxine Sodium tablets that may have been mislabeled as Isoniazid due to a labeling error.
Aidapak Services, LLC is recalling Bumetanide 1 mg tablets that may have been mislabeled as Guaifenesin ER 600 mg. The error could lead to incorrect medication administration.